<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04797663</url>
  </required_header>
  <id_info>
    <org_study_id>las177</org_study_id>
    <nct_id>NCT04797663</nct_id>
  </id_info>
  <brief_title>Long-pulsed 1064 nm Nd-YAG Laser Versus TCA 20% in Treatment of Keratosis Pilaris</brief_title>
  <official_title>Clinical and Dermoscopic Evaluation of Long-pulsed 1064 nm Nd-YAG Laser Versus Trichloroacetic Acid 20% in Treatment of Keratosis Pilaris</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Keratosis pilaris (KP) is a common disorder of keratinization. There are different treatment&#xD;
      modalities for KP with variable results. Nd:YAG laser and chemical peels are among these&#xD;
      treatment modalities, however, there is no enough evidence in the literature regarding their&#xD;
      efficacy. The aim of this study is to assess and compare the efficacy of long pulsed Nd:YAG&#xD;
      laser and trichloreacetic acid 20% in treatment of keratosis pilaris.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Keratosis pilaris (KP) is a genetic disorder of keratinization of hair follicles of skin.&#xD;
      It's a very common benign condition that manifests as small, rough folliculocentric keratotic&#xD;
      papules, often described as chicken bumps, chicken skin or goose-bumps, in characteristic&#xD;
      areas of body, particularly the outer upper arms and thighs.&#xD;
&#xD;
      Trichloreacetic acid (TCA) is a type of chemical peels that is derived from acetic acid by&#xD;
      the chlorination of 3 hydrogen ions. It can induce coagulative necrosis of proteins and&#xD;
      cells. The depth of action depends on various factors e.g the number of layers applied and&#xD;
      its combination with substances that potentiate its action.&#xD;
&#xD;
      Nd: YAG laser is a type of hair removing devices that operates at wave length of 1064nm. This&#xD;
      wave length allows for less absorption at the epidermis. It is less absorbed by melanin,&#xD;
      which leads to lower side effect and better tolerance but less efficacy in dark skinned&#xD;
      patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 17, 2021</start_date>
  <completion_date type="Actual">August 1, 2021</completion_date>
  <primary_completion_date type="Actual">July 18, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of clinical and dermoscopic scores of KP with Nd-YAG laser</measure>
    <time_frame>4 months</time_frame>
    <description>the change in roughness and color of KP by clinical score after 4 sessions of Nd-YAG laser. the score ranges from 0-4. where 0 is no change and 4 is excellent improvement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of clinical and dermoscopic scores of KP with TCA 20%</measure>
    <time_frame>4 months</time_frame>
    <description>the change in roughness and color of KP by clinical score after 4 sessions of TCA 20% peel. the score ranges from 0-4. where 0 is no change and 4 is excellent improvement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>safety and tolerability of Nd-YAG laser and TCA 20% in treatment of KP: adverse events</measure>
    <time_frame>4 months</time_frame>
    <description>adverse effects of treatment modalities, if any</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Keratosis Pilaris</condition>
  <arm_group>
    <arm_group_label>Nd-YAG laser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>laser hair removal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TCA 20%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>chemical peel</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nd-YAG laser</intervention_name>
    <description>laser hair removal device</description>
    <arm_group_label>Nd-YAG laser</arm_group_label>
    <other_name>1064 nm laser</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TCA 20%</intervention_name>
    <description>chemical peel</description>
    <arm_group_label>TCA 20%</arm_group_label>
    <other_name>Trichloroacetic acid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients above 18 years with KP.&#xD;
&#xD;
          -  Patients with KP affecting back of the trunk, arms, thighs, forearms, legs and&#xD;
             buttocks.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or lactating females.&#xD;
&#xD;
          -  Patients who had performed any laser treatment for KP within 6 months prior to the&#xD;
             study.&#xD;
&#xD;
          -  Patients with history of oral retinoids within 3 months prior to the study.&#xD;
&#xD;
          -  Patients with history of hypertrophic scars or keloids.&#xD;
&#xD;
          -  Patients who used any topical treatment one month prior to the session.&#xD;
&#xD;
          -  Patients with acne affecting the same sites of keratosis pilaris.&#xD;
&#xD;
          -  Patients with active skin diseases affecting the area involved with KP e.g.&#xD;
             folliculitis and eczema.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Akmal Saad, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kasr Alainy</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 6, 2021</study_first_submitted>
  <study_first_submitted_qc>March 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2021</study_first_posted>
  <last_update_submitted>August 1, 2021</last_update_submitted>
  <last_update_submitted_qc>August 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Dina Saadi</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratosis, Actinic</mesh_term>
    <mesh_term>Abnormalities, Multiple</mesh_term>
    <mesh_term>Darier Disease</mesh_term>
    <mesh_term>Keratosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

